HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Oliveira, K J Articles by Pazos-Moura, C C Search for Related Content PubMed PubMed Citation Articles by Oliveira, K J Articles by Pazos-Moura, C C

Laboratório de Endocrinologia Molecular, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21949-900, Brazil

(Requests for offprints should be addressed to C C Pazos-Moura; Email: cpazosm{at}biof.ufrj.br)

Peptide YY (PYY)_3-36 is a gut-derived hormone, with a proposed role in central mediation of postprandial satiety signals, as well as in long-term energy balance. In addition, recently, the ability of the hormone to regulate gonadotropin secretion, acting at pituitary and at hypothalamus has been reported. Here, we examined PYY_3-36 effects on thyrotropin (TSH) secretion, both in vitro and in vivo. PYY_3-36-incubated rat pituitary glands showed a dose-dependent decrease in TSH release, with 44 and 62% reduction at 10^–8 and 10^–6 M (P < 0.05 and P < 0.001 respectively), and no alteration in TSH response to thyrotropin-releasing hormone. In vivo, PYY_3-36 i.p. single injection in the doses of 3 or 30 cg/kg body weight, administered to rats fed ad libitum, was not able to change serum TSH after 15 or 30 min. However, in fasted rats, PYY_3-36 at both doses elicited a significant rise (approximately twofold increase, P < 0.05) in serum TSH observed 15 min after the hormone injection. PYY_3-36 treatment did not modify significantly serum T₄, T₃, or leptin. Therefore, in the present paper, we have demonstrated that the gut hormone PYY_3-36 acts directly on the pituitary gland to inhibit TSH release, and in the fasting situation, in vivo, when serum PYY_3-36 is reduced, the activity of thyroid axis is reduced as well. In such a situation, systemically injected PYY_3-36 was able to acutely activate the thyrotrope axis, suggesting a new role for PYY_3-36 as a regulator of the hypothalamic–pituitary–thyroid axis.

This article has been cited by other articles:

				M. A. L. C. da Veiga, F. Fonseca Bloise, R. H. Costa-e-Sousa, L. L. Souza, N. A. d. S. Almeida, K. J. Oliveira, and C. C. Pazos-Moura Acute effects of endocannabinoid anandamide and CB1 receptor antagonist, AM251 in the regulation of thyrotropin secretion J. Endocrinol., November 1, 2008; 199(2): 235 - 242. [Abstract] [Full Text] [PDF]